Categories AlphaGraphs, Earnings, Health Care
LLY Earnings: Highlights of Eli Lilly’s Q2 2024 financial report
Eli Lilly and Company (NYSE: LLY) on Thursday reported a double-digit increase in revenues and profit for the second quarter of 2024. The pharma giant also raised its full-year guidance.
Worldwide revenue increased 36% annually to $11.3 billion in the June quarter, driven mainly by strong sales of Mounjaro, Zepbound, and Verzenio.
Second-quarter reported net income increased 68% from last year to $3.0 billion, or $3.8 per share. Adjusted earnings climbed 86% year-over-year to $3.92 per share.
The management raised its full-year revenue guidance to the range of $45.4 billion to $ 46.6 billion. EPS forecast and adjusted EPS forecast have been raised to $15.10-15.60 and $16.10-16.60, respectively.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: FedEx looks set to report mixed results for Q4 2025
FedEx Corp. (NYSE: FDX) is preparing to report fourth-quarter earnings on Tuesday, June 24, at 4:00 pm ET. Recently, the management lowered its full-year earnings and revenue guidance for the
How Ulta Beauty’s (ULTA) new strategy is fueling growth
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) were up over 1% on Monday. The stock has gained 31% over the past three months. The beauty retailer started fiscal year 2025
Earnings Preview: What to look for when Kroger (KR) reports Q1 2025 results
The Kroger Co. (NYSE: KR) is expected to report its first-quarter financial results next week. Customer engagement remained stable last year, driven by high-quality products and tailored promotional offers. Recently,
